January 28, 2019

Cyclacel Ready for More Clinical Data After Positive 2018

Spiro Rombotis and Paul McBarron of Cyclacel Pharmaceuticals discuss the company's pipeline, indications, clinical data and more.
November 28, 2018

Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR

Mustang Bio (NASDAQ:MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T...